Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2024 10:25 ET | Source: Johnson Fistel, LLP

Akero Therapeutics Class Action Investigation: Johnson Fistel has Commenced an Investigation on Behalf of Shareholders

Individuals with nonpublic information should consider assisting our investigation or taking advantage of the SEC Whistleblower program.